<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
<text top="41" left="55" width="48" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>CytoJournal</i></text>
<text top="41" left="103" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2006, </text>
<text top="41" left="131" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>3</b></text>
<text top="41" left="136" width="12" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:18</text>
<text top="41" left="387" width="167" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.cytojournal.com/content/3/1/18</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t6" reading_order_no="114" segment_no="7" tag_type="text">Page 6 of 8</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="115" segment_no="8" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="text">bladder tumors. A sensitivity of 90% and specificity of</text>
<text top="98" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="2" tag_type="text">88% was achieved for bladder cancer detection by apply-</text>
<text top="110" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="2" tag_type="text">ing relative cut-off points to a quantitative TRAP assay</text>
<text top="122" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="2" tag_type="text"><a href="">[26]. Te</a>lomerase activity determination by the TRAP assay</text>
<text top="134" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="2" tag_type="text">enables quantitative evaluations to be made, but is vul-</text>
<text top="145" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="2" tag_type="text">nerable to contamination by telomerase-positive, non-</text>
<text top="157" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="2" tag_type="text">malignant cell types, such as proliferative stem cells and</text>
<text top="169" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="2" tag_type="text">inflammatory elemen<a href="">ts [27</a>,<a href="">28]. Furthe</a>rmore, because the</text>
<text top="181" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="2" tag_type="text">TRAP assay detects enzyme activity and not simply the</text>
<text top="192" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="2" tag_type="text">presence of the protein, valid findings require the pres-</text>
<text top="204" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="2" tag_type="text">ence of living cells. In native urine, suspended cells are</text>
<text top="216" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="2" tag_type="text">exposed for various lengths of time to destructive sub-</text>
<text top="228" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="2" tag_type="text">stances and conditions including proteases, urea, and</text>
<text top="239" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="2" tag_type="text">acidic pH <a href="">values [10</a>]. The alternative to the TRAP assay is</text>
<text top="251" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="2" tag_type="text">detection of the structural or encoding RNA components</text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="2" tag_type="text">of the telomerase enzyme, primarily the human telomer-</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="2" tag_type="text">ase RNA component (hTR) and hTERT mRNA</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="2" tag_type="text"><a href="">[10,21,27</a>,<a href="">28</a>]. Compared to other urine-based markers,</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="2" tag_type="text">quantitative detection of human telomere components by</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="2" tag_type="text">RT-PCR, particularly the RNA component (hTR), shows</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="2" tag_type="text">acceptable diagnostic accuracy with sensitivities of up to</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="2" tag_type="text">77% (29). Clearly, telomerase is a promising marker for</text>
<text top="345" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="2" tag_type="text">urothelial neoplasia, but these tests remain several steps</text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="2" tag_type="text">removed from becoming a routine procedure which</text>
<text top="369" left="55" width="147" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="2" tag_type="text">replaces cytology. In contrast, an </text>
<text top="369" left="202" width="30" height="9" font="font5" id="p1_t33" reading_order_no="30" segment_no="2" tag_type="text"><i>in situ </i></text>
<text top="369" left="232" width="64" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="2" tag_type="text">analysis would</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="32" segment_no="2" tag_type="text">enable the morphological identification of hTERT-posi-</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="2" tag_type="text">tive cells, and if used as an adjunct to cytology such anal-</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="2" tag_type="text">yses could be rapidly brought into practice. Good</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="2" tag_type="text">monoclonal antibodies that specifically recognize hTERT</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="2" tag_type="text">have been isolated only recently so few studies have</text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="2" tag_type="text">focused on the immunohistochemical evaluation of</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="2" tag_type="text">hTERT in human tissues. In the current study, we demon-</text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="2" tag_type="text">strated the feasibility of an hTERT immunoexpression</text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="2" tag_type="text">assay on urine sediment samples, and investigated its util-</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="2" tag_type="text">ity as an adjunct to conventional urine cytology in the</text>
<text top="498" left="55" width="135" height="9" font="font4" id="p1_t45" reading_order_no="42" segment_no="2" tag_type="text">diagnosis of bladder carcinoma.</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="5" tag_type="text">Our study has shown that through the application of a</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="5" tag_type="text">monoclonal antibody, hTERT can reliably be detected in</text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="5" tag_type="text">paraffin-embedded solid tumor specimens and in urine</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="5" tag_type="text">sediments archived as cell blocks. In agreement with the</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="5" tag_type="text">few previous reports describing hTERT protein localiza-</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="5" tag_type="text">tion, we found hTERT to be localized to the nucleolus</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="5" tag_type="text"><a href="">[13,30,31</a>]. It is logical that hTERT is localized predomi-</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="5" tag_type="text">nantly in the nucleolus, the site of nucleoprotein complex</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="5" tag_type="text">assembly, because hTERT is a subunit of the ribonucleo-</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="5" tag_type="text">protein telomerase en<a href="">zyme [10</a>]. In bladder tumor biopsy</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="5" tag_type="text">material we observed hTERT expression in cells adjacent</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="5" tag_type="text">to the tumor and expression was seen to diminish more</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="5" tag_type="text">distal to the primary lesion. This spatially associated</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="5" tag_type="text">hTERT positivity in apparently normal cells has been</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="5" tag_type="text">observed in other organs, including the colo<a href="">n [13]</a>, pros-</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="5" tag_type="text">tate [<a href="">30]</a> and melanocytic <a href="">lesions [31]. Th</a>e development</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="5" tag_type="text">of a reliable hTERT antibody has revealed this phenome-</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t63" reading_order_no="60" segment_no="5" tag_type="text">non and has the potential to better determine exactly</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="3" tag_type="text">where hTERT is expressed at the cellular level. The expres-</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="3" tag_type="text">sion in normal cells could result from a number of possi-</text>
<text top="110" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="3" tag_type="text">bilities, but the spatial relationship suggests that factors</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="3" tag_type="text">secreted from the tumor can induce hTERT transcription/</text>
<text top="134" left="313" width="146" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="3" tag_type="text">translation in non-neoplastic cells.</text>
<text top="157" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="4" tag_type="text">Our goal was to evaluate the potential utility of hTERT</text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="4" tag_type="text">immunodetection in urine sediments as an adjunct to</text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="4" tag_type="text">cytology. Given the nature of the sample, which is often</text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="4" tag_type="text">composed of scanty, dispersed cells, we did not attempt to</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="4" tag_type="text">estimate staining intensity or percentage of immunoreac-</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="4" tag_type="text">tive cells within the sample or block section. In this study,</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="4" tag_type="text">the presence (&gt;3 cells observed) or absence of hTERT, spe-</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="4" tag_type="text">cifically in transitional urothelial cells, was noted. The</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="4" tag_type="text">expression of hTERT was observed in 85% of the histolog-</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="4" tag_type="text">ically confirmed bladder cancer cases, which represents a</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t79" reading_order_no="76" segment_no="4" tag_type="text">high rate of diagnostic sensitivity by examination of</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t80" reading_order_no="77" segment_no="4" tag_type="text">voided urine. Overall, the hTERT immunoassay demon-</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t81" reading_order_no="78" segment_no="4" tag_type="text">strated a positive predictive value of 77.8% and a negative</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t82" reading_order_no="79" segment_no="4" tag_type="text">predictive value of 75% in this study. The hTERT assay</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="4" tag_type="text">showed higher diagnostic sensitivity (84.8%) than pub-</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="4" tag_type="text">lished urine cytology data (~65%) for confirmed bladder</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="4" tag_type="text">carcinoma, however, the specificity of the hTERT immu-</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="4" tag_type="text">noassay was 80%, lower than that obtained by cytologic</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="4" tag_type="text">evaluation (~90%). The specificity data do not support</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t88" reading_order_no="85" segment_no="4" tag_type="text">the use of hTERT immunodetection as a replacement for</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="4" tag_type="text">cytology, but the improved sensitivity of the assay sug-</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="4" tag_type="text">gests potential utility as an adjunct to cytology. It was</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t91" reading_order_no="88" segment_no="4" tag_type="text">notable that the majority of false-positive cases were</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t92" reading_order_no="89" segment_no="4" tag_type="text">found in the subset classified as cytologically atypical, but</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t93" reading_order_no="90" segment_no="4" tag_type="text">which have no evidence of disease to date. It will be inter-</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="4" tag_type="text">esting to see whether these patients will subsequently</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="4" tag_type="text">develop bladder malignancy in which case hTERT detec-</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t96" reading_order_no="93" segment_no="4" tag_type="text">tion may have potential as an early detection or even pre-</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="4" tag_type="text">dictive marker. However, specimens from patients with a</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t98" reading_order_no="95" segment_no="4" tag_type="text">history of bladder cancer are often deemed atypical cyto-</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t99" reading_order_no="96" segment_no="4" tag_type="text">logically, due to a 'field-effect', and in this study several</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="4" tag_type="text">cases were immunoreactive for hTERT. In agreement with</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="4" tag_type="text">telomerase activity assays in such patien<a href="">ts [28</a>], we did</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="4" tag_type="text">find hTERT-positive cells in patients who had no evidence</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t103" reading_order_no="100" segment_no="4" tag_type="text">of urothelial lesion at the time of sampling, but who did</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t104" reading_order_no="101" segment_no="4" tag_type="text">have a history of bladder cancer. Thus, it seems that hTERT</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t105" reading_order_no="102" segment_no="4" tag_type="text">detection may not be reliable in the monitoring of recur-</text>
<text top="592" left="313" width="83" height="9" font="font4" id="p1_t106" reading_order_no="103" segment_no="4" tag_type="text">rent bladder cancer.</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t107" reading_order_no="104" segment_no="6" tag_type="text">Our findings are in agreement with the previous telomer-</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t108" reading_order_no="105" segment_no="6" tag_type="text">ase-based studies in urological cancers, in that telomerase</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t109" reading_order_no="106" segment_no="6" tag_type="text">expression correlates with malignancy, but the use of</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t110" reading_order_no="107" segment_no="6" tag_type="text">immunohistochemistry adds specific advantages in the</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t111" reading_order_no="108" segment_no="6" tag_type="text">context of diagnosis. Although assays such as the TRAP</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t112" reading_order_no="109" segment_no="6" tag_type="text">assay or mRNA measurement can be designed to be semi-</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t113" reading_order_no="110" segment_no="6" tag_type="text">or fully quantitative, they do not provide information</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t114" reading_order_no="111" segment_no="6" tag_type="text">regarding the source of the protein. Immunohistochemi-</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t115" reading_order_no="112" segment_no="6" tag_type="text">cal studies are beginning to reveal that normal cells can</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t116" reading_order_no="113" segment_no="6" tag_type="text">express hTERT under certain circumstances. In our study,</text>
</page>
</pdf2xml>
